ArticleFrontiers in bioengineering and biotechnology2026
A pH-Triggered antibacterial and lubricating dual-function hydrogel coating for infection-resistant urinary catheters.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.Autophagy · 2026Article
- Functional hydrogel biomaterials for urological diagnosis and treatment-design strategies and application progress: a review.Journal of materials science. Materials in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Urinary catheterization frequently causes urinary tract infections and patient discomfort. While hydrogel coatings combining antibacterial and hydrophilic properties offer a potential solution, challenges such as uncontrolled antimicrobial release and poor coating adhesion limit their clinical utility. This study aimed to develop a novel dual-function hydrogel coating with controlled antibacterial activity and sustained lubrication for infection-resistant urinary catheters. Methods: A bilayer PL@SAMT/Mg coating consisting of an inner polydopamine layer loaded with the antimicrobial peptide LL-37 and an outer pH-responsive MgO@AAm/SA/TA hydrogel was fabricated via surface modification and UV crosslinking. The coating was applied to catheters via surface modification followed by UV-induced crosslinking. It was characterized using SEM, EDS, FTIR, rheometry, and friction tests. Its antibacterial efficacy was evaluated against Staphylococcus aureus and Escherichia coli at different pH levels. Cytocompatibility was assessed using CCK-8, live/dead staining, and ELISA assays with L929, SV-HUC-1, and RAW264.7 cells. In vivo biocompatibility and antibacterial performance were investigated using a rat subcutaneous implantation model. Results: The PL@SAMT/Mg coating exhibited a uniform, adherent bilayer structure with stable mechanical properties. It delivered excellent hydration lubrication and demonstrated pH-responsive swelling behavior. The release of LL-37 was sustained, while MgO release was significantly accelerated under alkaline conditions mimicking infection. The coating showed strong, pH-enhanced antibacterial activity against both S. aureus and E. coli. In vitro assays confirmed excellent cytocompatibility, anti-inflammatory effects, and anti-adhesion properties. In vivo, the coating minimized inflammation and significantly reduced bacterial colonization compared to uncoated catheters. Discussion: The PL@SAMT/Mg coating successfully integrates intelligent antibacterial function with sustained lubrication. The PDA layer enables long-term preventive release of AMPs, while the pH-responsive hydrogel layer provides on-demand MgO release during infection. This synergistic, controlled-release strategy mitigates biotoxicity and resistance risks. The coating addresses key limitations of existing technologies through robust adhesion, effective antibacterial action, and biocompatibility, offering a promising approach to improve catheter performance and patient comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.